Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SEZI.ST
- Price
- 3.83
- Stock movement up
- +0.15 (4.07%)
- Company name
- Senzime AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Devices
- Market cap
- 508.04M
- Ent value
- 528.01M
- Price/Sales
- 9.19
- Price/Book
- 1.78
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 20.50%
- 1 year return
- -39.22%
- 3 year return
- -41.36%
- 5 year return
- -24.92%
- 10 year return
- -2.51%
Last updated: 2025-04-15
DIVIDENDS
SEZI.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 9.19 |
| Price to Book | 1.78 |
| EV to Sales | 9.55 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 132.47M |
| EPS (TTM) | -1.10 |
| FCF per share (TTM) | -1.08 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 55.29M |
| Gross profit (TTM) | 18.02M |
| Operating income (TTM) | -134.27M |
| Net income (TTM) | -131.46M |
| EPS (TTM) | -1.10 |
| EPS (1y forward) | -0.43 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 32.58% |
| Operating margin (TTM) | -242.84% |
| Profit margin (TTM) | -237.75% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 50.24M |
| Net receivables | 14.22M |
| Total current assets | 98.24M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 26.19M |
| Total assets | 355.25M |
| Accounts payable | 7.65M |
| Short/Current long term debt | 22.76M |
| Total current liabilities | 27.59M |
| Total liabilities | 70.21M |
| Shareholder's equity | 285.04M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -113.49M |
| Capital expenditures (TTM) | 15.33M |
| Free cash flow (TTM) | -128.83M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -46.12% |
| Return on Assets | -37.01% |
| Return on Invested Capital | -45.57% |
| Cash Return on Invested Capital | -44.66% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.85 |
| Daily high | 3.88 |
| Daily low | 3.70 |
| Daily Volume | 117K |
| All-time high | 26.14 |
| 1y analyst estimate | 12.25 |
| Beta | 0.59 |
| EPS (TTM) | -1.10 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 5 May 2025 |
Downside potential
Loading...
Downside potential data
| SEZI.ST | S&P500 | |
| Current price drop from All-time high | -85.33% | -12.04% |
| Highest price drop | -88.77% | -56.47% |
| Date of highest drop | 26 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -39.13% | -11.07% |
| Avg time to new high | 74 days | 12 days |
| Max time to new high | 1152 days | 1805 days |
COMPANY DETAILS
Marketcap
508.04M
Marketcap category
Small-cap
Description
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. It offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance to measure the tissue's opposition to carrying an alternating electrical current. The company has a strategic connectivity and licensing agreement with Masimo to develop, manufacture, market, and distribute products that can connect to the Masimo Root patient monitoring system and related digital hub for data transmission to hospital electronic patient journals; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system. Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.
Employees
52
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
UPPSALA, SWEDEN / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to a webcast presentation of the first quarter report for 2025 on April 22, ...
April 14, 2025
UPPSALA, SE / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby convened to an annual gene...
April 14, 2025
UPPSALA, SE / ACCESS Newswire / April 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Uppsala, Sweden - Senzime comments on the April 2 announcement on imposed new US import tariffs effective April 9, 202...
April 3, 2025
UPPSALA, SE / ACCESS Newswire / April 1, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The number of shares and votes in Senzime has increased during the month of March due to the directed issue of shares ...
April 1, 2025
UPPSALA, SE / ACCESS Newswire / March 14, 2025 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured new important US hospital system contracts including initial delivery of 60 next...
March 14, 2025
Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB's (publ) interim report for January - December 2024 is now available on the company's website www.senzime.com. Financial information October - December 2024 ...
February 17, 2025
Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter report for 2024 on February 17, 14:00 CET. The report will be published d...
February 13, 2025
UPPSALA, SWEDEN / ACCESSWIRE / January 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.), a leader in precision-based patient monitoring, today announced that the company has reached a sec...
January 13, 2025
UPPSALA, SE / ACCESSWIRE / January 7, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime,an industry leader in precision-based patient monitoring solutions, today announced multiple hospital contract wins...
January 7, 2025
UPPSALA, SE / ACCESSWIRE / November 06, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Press release: Uppsala, November 6th, 2024. Senzime AB's (publ) interim report for January - September 2024 is now availa...
November 6, 2024
Next page